Minerva Neurosciences | NERV - Funcionários Número total

Preço das Ações
5.51
Mudança Diária
-0.51 -8.47%
Mensal
-24.52%
Anual
280.00%
Q2 Previsão
5.36




Funcionários Alterar Data
Acadia Pharmaceuticals 653 56 2024-12
Adma Biologics 624 7 2023-12
ALKERMES 1.8K 300 2024-12
Alterity Therapeutics Limited AUD 12 1 2022-06
AstraZeneca USD 89.9K 6.4K 2023-12
BioCryst Pharmaceuticals 536 5 2023-12
Bristol-Myers Squibb 34.1K 0 2024-12
Cipla 30.31K 2.55K 2025-12
Clal Biotechnology 3 191 2023-12
Compugen USD 74 6 2024-12
CSL USD 32.06K 1.67K 2025-12
Eli Lilly 47K 4K 2024-12
Esperion Therapeutics 240 41 2023-12
GlaxoSmithKline 69.4K 20.7K 2022-12
Grifols EUR 23.83K 89 2024-12
Halozyme Therapeutics 350 23 2024-12
Ionis Pharmaceuticals 1.07K 142 2024-12
J&J 138.1K 6.2K 2024-12
Merck 75K 3K 2024-12
Minerva Neurosciences 9 0 2023-12
Neurocrine Biosciences 1.8K 400 2024-12
Novartis USD 101.7K 2.62K 2022-12
Novavax 1.54K 449 2023-12
Pfizer 81K 7K 2024-12
Roche Holding 103.61K 2.69K 2022-12
Sanofi 84.59K 3.41K 2024-12
Takeda 47.46K 1.83K 2025-12
Vanda Pharmaceuticals 203 87 2023-12